Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
620.00    0.00 (0.00%)
Bid:
619.50
Ask:
620.50
Spread: 1.00 (0.161%)
Market Cap: £2.87b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

3rd Quarter Trading Update

28 Jan 2025 07:00

RNS Number : 8617U
RS Group PLC
28 January 2025
 

 

28 January 2025, 7.00am

 

RS GROUP PLC

 

Trading update for third quarter ended 31 December 2024

 

RS Group plc, the global distributor of maintenance, repair and operation product and service solutions to industrial customers, provides the following trading update for the three months ended 31 December 2024.

Group revenue in the third quarter decreased by 3% and by 1% on like-for-like1 basis. This reflects declining industrial production and PMI2 data, and weaker trading in the second half of December due to more extended holiday-related plant shutdowns at many customers.

In EMEA, like-for-like revenue declined 3% with softness in key markets consistent with weaker business sentiment and PMIs across the region. This was particularly true in the UK, where we have seen a material slowdown from the beginning of November. Like-for-like revenue in Americas grew by 3%, mainly due to improvement in the US and strong sales growth in Mexico. Asia Pacific like-for-like revenue increased by 1%.

We are implementing our strategic plan at pace and making good underlying progress with improvements to our digital and technology platform, product and own-brand offer, customer service capabilities and in our execution. This is driving continued share gain in most product categories. Our operational efficiency initiatives and integration benefits are in-line or ahead of plan, and we are on track to deliver annualised cost savings in excess of £30 million this year. Our multi-year investment programme to improve process and systems efficiencies is also progressing well.

We continue to control costs tightly and therefore our prior gross margin and cost guidance3 remains unchanged. The softer than expected Q3 revenue performance and weak business confidence in EMEA will however likely result in full year profit before tax being around the bottom end of the consensus range4. January trading is in line with our revised expectations, and we will continue investing in our key strategic initiatives whilst managing costs effectively in this difficult trading environment which we expect to continue until we see a more sustained improvement in PMIs.

 

Simon Pryce, Chief Executive Officer, said:

"We are making good underlying strategic progress and executing better which is continuing to drive efficiency and share gains despite market conditions. We are managing our cost base effectively whilst continuing to invest to further strengthen our already differentiated proposition. This is better positioning RS to generate stronger and more sustainable growth and returns in the future, which will accelerate when the market recovers."

 

Notes:

1. Like-for-like revenue excluding acquisitions and adjusted for foreign currency and trading days.

2. Purchasing manager index (PMI) is a survey-based economic indicator designed to provide a timely insight into business conditions. The PMI is widely used to anticipate changing economic trends in official data such as GDP, or sometimes as an alternative gauge of economic performance and business conditions to official data, as the latter sometimes suffer from delays in publication, poor availability or data quality issues (Source: S&P Global).

3. Guidance provided at interim results, 7 November 2024. Source: rsgroup.com/investors/result-reports-and-presentations/.

4. Consensus estimates for the year ended 31 March 2025 are revenue of £2,911 million (range of £2,871 million - £3,011 million), adjusted operating profit of £293 million (range of £277 million - £306 million) and adjusted profit before tax of £261 million (range of £247 million - £274 million). Source: rsgroup.com/investors/analyst-consensus/.

5. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2024 for euro and US dollar respectively were €1.159 and $1.257 respectively. Every 1 cent movement in the euro has a c. £2.0 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar has a c. £0.7 million impact on annual adjusted profit before tax.  

6. We expect to see a positive impact of around £29 million on revenue from greater trading days in 2024/25 compared to 2023/24.  

 

Enquiries:

Kate Ringrose

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Teneo Communications

020 7353 4200

 

 

Conference call details:

There will be an audio-only call for analysts and investors today at 8.00am UK time.

 

Conference call timing

Date: Tuesday 28 January

Time: 8.00am GMT / UK

 

Webcast link (audio only): https://webcast.openbriefing.com/rsgroup-jan25/

Conference call dial-in number: +44 20 3936 2999

Access code: 741313

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUMGGUPAGBM
Date   Source Headline
17th Jun 202610:00 amRNSHolding(s) in Company
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 202612:00 pmRNSAnnual Financial Report and Notice of AGM
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 202610:00 amRNSDirector/PDMR Shareholding
2nd Jun 20263:55 pmRNSDirector Declaration
1st Jun 202612:43 pmRNSHolding(s) in Company
1st Jun 20269:44 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:01 amRNSCommencement of Share Buyback Programme
20th May 20267:00 amRNSFinal Results
1st Apr 20265:06 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSPre-Close Trading Update
3rd Mar 20267:00 amRNSAcquisition of BPX Group
6th Jan 20264:00 pmRNSDirector/PDMR Shareholding
12th Dec 20253:14 pmRNSDirectorate change
4th Dec 202510:00 amRNSDirector/PDMR Shareholding
20th Nov 20254:20 pmRNSReplacement Holding(s) in Company
20th Nov 20253:30 pmRNSHolding(s) in Company
7th Nov 20253:56 pmRNSHolding(s) in Company
6th Nov 20257:00 amRNSHalf-year Financial Report
1st Sep 20254:30 pmRNSHolding(s) in Company
12th Aug 20254:30 pmRNSHolding(s) in Company
8th Aug 20254:00 pmRNSHolding(s) in Company
1st Aug 202511:02 amRNSBlock listing Interim Review
21st Jul 20254:00 pmRNSDirector/PDMR Shareholding
17th Jul 20253:15 pmRNSResult of AGM
17th Jul 20257:00 amRNSAGM Update
4th Jul 202510:00 amRNSDirectorate Change - Chair of Audit Committee
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jun 20259:00 amRNSDirector/PDMR Shareholding
18th Jun 20254:30 pmRNSDirector/PDMR Shareholding
10th Jun 202511:00 amRNSHolding(s) in Company
9th Jun 202512:00 pmRNSAnnual Financial Report and Notice of AGM
6th Jun 20252:00 pmRNSDirector/PDMR Shareholding
29th May 202510:00 amRNSDirector/PDMR Shareholding
21st May 20257:00 amRNSFinal Results
23rd Apr 20254:30 pmRNSDirector/PDMR Shareholding
28th Mar 20252:30 pmRNSDirector/PDMR Shareholding
26th Mar 202511:00 amRNSDirector/PDMR Shareholding
21st Feb 202510:00 amRNSDirectorate Change
3rd Feb 202510:39 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNS3rd Quarter Trading Update
8th Jan 20259:13 amRNSDirector Declaration
7th Jan 20252:38 pmRNSDirector Declaration
29th Nov 20248:30 amRNSDirectorate Change
7th Nov 20247:00 amRNSHalf-year Report
1st Oct 20249:46 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSInvestor Event: The RS Opportunity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.